ライフサイエンスコーパス: co-infected

1 rhosis who were HCV mono-infected or HIV/HCV co-infected.

2 ); worldwide more than 15 million people are co-infected.

3 DR tuberculosis who were tested for HIV were co-infected.

4 Twelve HCV/HIV-co-infected and 15 HCV-monoinfected patients underwent v

5 brosis in 8% of all patients (31% in HIV/HCV co-infected and 3% in HIV mono-infected individuals).

6 gorithms and treatment regimens for both HIV co-infected and hepatitis C mono-infected patients are s

7 s undetectable at 72 weeks in 25% and 40% of co-infected and monoinfected patients, respectively.

8 Interestingly, the Th2 response in the co-infected animals did not impair the onset and develop

9 pathway to the heightened susceptibility of co-infected animals.

10 pe 1 to 4 are virtually identical in the HIV co-infected as in the HCV monoinfected, regardless of wh

11 node germinal center B cell response between co-infected C3H and B6 mice.

12 antigen-specific antibody-producing cells in co-infected C3H mice compared to B6 mice as early as 2 w

13 doplasmic reticulum (ER) and PM fractions of co-infected cells by the anti-FLAG antibody demonstrates

14 nd concomitant HIV-1, HIV-2 transcription in co-infected cells.

15 replication of wild-type HSV-1 and HSV-2 in co-infected cells.

16 prevent the replication of wild-type HSV in co-infected cells.

17 ys of co-infection, and after 4 weeks 95% of co-infected fleas contained an average of 103 antibiotic

18 were hepatitis B-co-infected or hepatitis C-co-infected, had new AIDS-defining conditions within 30

19 peted if has competitive advantages within a co-infected host.

20 spore-trapping experiment demonstrates that co-infected hosts shed more transmission propagules than

21 and yet malaria populations were smaller in co-infected hosts.

22 istic Th1/Th2 immune response that occurs in co-infected hosts.

23 miR-122 and miR-200a are greater in HIV/HCV co-infected individuals compared to HIV-1 mono-infected

24 red with individuals infected with only HIV, co-infected individuals had a higher risk of death from

25 d/or AIDS-related mortality was higher among co-infected individuals than those with only HIV infecti

26 an achieve similar response rates in HCV/HIV-co-infected individuals with no adverse effect on HIV RN

27 g no primary data, samples of HCV or HIV-HCV co-infected individuals, or samples relying on self-repo

28 an unpredictable exacerbation of disease in co-infected individuals.

29 eds to be improved for both monoinfected and co-infected individuals.

30 lly changed over time and between single and co-infected individuals.

31 These were simultaneously co-infected into Sf9 insect cells with recombinant bacul

32 ation, and greater lung pathology in the Mtb-co-infected lung.

33 Co-infected mice lacking interleukin (IL) 4Ralpha exhibi

34 Colonic epithelial preparations from co-infected mice showed increased expression of c-myc (5

35 creases the bacterial burden in the lungs of co-infected mice.

36 nofluorescent methods, we determined whether co-infected neurons express MCH or orexin.

37 e excluded patients if they were hepatitis B-co-infected or hepatitis C-co-infected, had new AIDS-def

38 HIV/HBV-co-infected participants with detectable HBV DNA prior t

39 XDR tuberculosis has been transmitted to HIV co-infected patients and is associated with high mortali

40 ations predict virologic response in HIV/HCV co-infected patients and to examine variables associated

41 itis C virus (HCV) mono-infected and HIV/HCV co-infected patients are in need of safe, effective, all

42 ths related to HIV in the United States, and co-infected patients bear a significant proportion of th

43 mmunodeficiency virus type 1 (HIV-1) and HBV-co-infected patients because it had been reported that E

44 Compared with HCV-monoinfected patients, co-infected patients had a higher rate of hepatic decomp

45 High mortality rates in co-infected patients have improved with antiretroviral t

46 drug-resistant tuberculosis (XDR-TB) and HIV co-infected patients in South Africa.

47 Co-infected patients may require longer treatment durati

48 ofile and SVR12 rates of 96.7% among HIV/HCV co-infected patients participating in an Italian compass

49 HCV/human immunodeficiency virus (HIV)-co-infected patients show lower response rates vs. HCV-m

50 study of vitamin D supplementation in HIV-TB co-infected patients starting ART.

51 or without ribavirin (arms B1-3) and HIV/HCV co-infected patients to 12 weeks of therapy with or with

52 SVR12 rates in mono-infected and co-infected patients treated for 12 weeks without ribavi

53 Co-infected patients were randomized within a US multice

54 Co-infected patients who maintained HIV RNA levels less

55 Rates of decompensation were higher for co-infected patients with advanced liver fibrosis, sever

56 usly untreated HCV-mono-infected and HIV/HCV-co-infected patients without cirrhosis achieved SVR12 ra

57 the context of human immunodeficiency virus co-infected patients, has threatened global TB control.

58 the standard treatment for HCV infection for co-infected patients, who have the greatest risk for liv

59 Predicted clearance time increased by 28% in co-infected patients.

60 t ribavirin was similar in mono-infected and co-infected patients.

61 d from 93-98% in mono-infected and 87-97% in co-infected patients.

62 ed with higher rates of decompensation among co-infected patients.

63 V infection has emerged as major concern for co-infected patients.

64 tiation during antituberculosis treatment in co-infected patients.

65 cost of an increased risk of WNV disease in co-infected patients.

66 HIV/CMV co-infected persons despite prolonged viral suppression

67 We show that HIV/CMV co-infected persons with virologic suppression and recov

68 d more rapid progression of complications in co-infected persons.

69 Here, experimentally co-infected pigs with a representative EA virus and a pd

70 In co-infected primary mouse macrophages, FeoB is required

71 In a subgroup analysis of mono- and co-infected subjects some associations lost significance

72 of hepatic decompensation was greater among co-infected than monoinfected patients (7.4% vs. 4.8% at

73 the antagonism of the viroid on the virus in co-infected tomato plants.

74 n, we find the highest disease prevalence in co-infected treatments both at the host genotype and pop

75 inetic parameters and treatment responses in co-infected vs monoinfected patients.

76 DNA barcode sequence by allelic exchange and co-infected with a wild-type reference to calculate the

77 Patients co-infected with advanced HIV and tuberculosis are at ri

78 ose consequences are less severe if cats are co-infected with an attenuated FIV strain (PLV).

79 ecies in North America, could potentially be co-infected with avian and human IAVs, facilitating the

80 heterophil to lymphocyte ratios and were all co-infected with avian malaria, consistent with evidence

81 One quarter of states require persons co-infected with HCV and HIV to be receiving antiretrovi

82 lts of this study generalize to all patients co-infected with HCV and HIV.

83 uncontrolled, pilot study enrolling patients co-infected with HCV genotype 1 and HIV, administration

84 en resulted in high SVR rates among patients co-infected with HCV genotype 1 and HIV-1 whether treate

85 V-1-infected patients, two of whom were also co-infected with HCV.

86 e following transplantation than in patients co-infected with hepatitis C (37 +/- 9 vs. 70 +/- 33 U/L

87 frequently found in transplantation patients co-infected with hepatitis C although it appears to have

88 Persons co-infected with hepatitis C virus (HCV) and HIV.

89 Patients co-infected with hepatitis C virus (HCV) and human immun

90 s6-Cdc25C immunoprecipitated from sf-9 cells co-infected with His6-Prk and His6-Cdc25C baculoviruses,

91 When co-infected with His6-Prk and His6-Cdc25C recombinant ba

92 n American, and 13% were Caucasian; 27% were co-infected with HIV and 67% had no or mild fibrosis.

93 eron-free regimens are approved for patients co-infected with HIV and genotype-2 or genotype-3 hepati

94 based regimens are still an option for those co-infected with HIV and HCV genotypes 1 or 4.

95 ent-naive and treatment-experienced patients co-infected with HIV and HCV genotypes 1-4.

96 Despite receiving ART, patients co-infected with HIV and HCV had higher rates of hepatic

97 therapy became widely available, individuals co-infected with HIV and HCV have had a higher risk of d

98 Also, patients co-infected with HIV and HCV in 2001 constituted 7.5 tim

99 emonstrate the optimal management of persons co-infected with HIV and HCV.

100 deline-recommended treatment for individuals co-infected with HIV and hepatitis B, this regimen might

101 ve been incompletely examined among patients co-infected with HIV and hepatitis C virus (HCV) in the

102 %) had no additional restrictions for people co-infected with HIV and hepatitis C virus.

103 during ART should be considered in patients co-infected with HIV and tuberculosis.

104 onsider women, Hispanic persons, or patients co-infected with HIV or hepatitis B virus.

105 be effective and well tolerated for patients co-infected with HIV with or without cirrhosis.

106 tuberculosis and high mortality among those co-infected with HIV-1 necessitates new therapeutic appr

107 rom 74 out of 344 patients, 48 of these were co-infected with HIV.

108 cine efficacy against CIN2+, where all cases co-infected with HPV-16/18 were removed, vaccine efficac

109 Patients co-infected with human immunodeficiency virus (HIV) and

110 epatitis C virus (HCV) infection in patients co-infected with human immunodeficiency virus (HIV).

111 nose BTB is reduced in cattle experimentally co-infected with M. bovis and F. hepatica.

112 lls to tissue macrophages, many of which are co-infected with opportunistic pathogens.

113 rcine alveolar macrophages (PAM) cells model co-infected with PRRSV/PCV2 with modification in vitro,

114 stem and immunoprecipitation of insect cells co-infected with RAD51 and RAD52 recombinant viruses, an

115 One matriline was co-infected with Rickettsia and Wolbachia and produced o

116 Animals co-infected with SIVmac251 and M. avium developed progre

117 We enrolled patients (aged >/=18 years) co-infected with stable HIV and chronic HCV genotypes 1-

118 tortaeformis intensity decreased faster when co-infected with the bacterium.

119 iretroviral-induced liver injury in patients co-infected with the human immunodeficiency virus and in

120 d mice were protected when these agents were co-infected with the neuroinvasive strain.

121 This restriction is overcome when cells are co-infected with vaccinia virus (VACV), a vertebrate DNA

122 Cells were simultaneously co-infected with viruses encoding alpha-His/beta and alp

123 (and other body fluids) in 66 HIV- and HHV-8-co-infected women without KS so that we could examine pr